Verition Fund Management LLC

Position in SNDX — Syndax Pharmaceuticals Inc

CIK 1454027 GREENWICH, CT

Position in SNDX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$6,665,966

+$6,278,122 QoQ

Shares Held

304,939

+1551.9% QoQ

Ownership

0.341%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#64

of 240 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Verition Fund Management LLC holds $152,220,097 across 64 Biotechnology names. SNDX ranks #5 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TECH	BIO-TECHNE Corp	438,746	$30,997,404
2	APGE	Apogee Therapeutics, Inc.	159,256	$21,138,048
3	ABVX	Abivax S.A.	105,791	$14,097,708
4	IDYA	IDEAYA Biosciences, Inc.	184,054	$6,859,692
5	SNDX	Syndax Pharmaceuticals Inc This page	304,939	$6,665,966
6	MRVI	Maravai Lifesciences Holdings, Inc.	777,738	$4,853,085
7	CYTK	Cytokinetics Inc	54,889	$4,675,993
8	RPRX	Royalty Pharma plc	75,000	$4,205,250

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,665,966	304,939	+1551.9%	Shares	Sole	2026-08-14
2025-12-31	$387,844	18,460	+7.5%	Shares	Sole	2026-02-13
2025-09-30	$264,298	17,179	-86.3%	Shares	Sole	2025-11-14
2025-06-30	$1,173,855	125,345	+257.8%	Shares	Sole	2025-08-14
2025-03-31	$430,429	35,037	-55.8%	Shares	Sole	2025-05-15
2024-09-30	$1,527,314	79,341	-45.1%	Shares	Sole	2024-11-14
2024-06-30	$2,967,939	144,566	-58.3%	Shares	Sole	2024-08-14
2024-03-31	$8,255,315	346,862	+142.1%	Shares	Sole	2024-05-14
2023-12-31	$3,095,978	143,266	+855.1%	Shares	Sole	2024-02-14
2023-09-30	$217,800	15,000	+39.7%	Shares	Sole	2023-11-14
2022-09-30	$258,010	10,737	-87.9%	Shares	Sole	2023-01-18
2020-12-31	$1,970,352	88,595	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.